Steve Schonfeld Schonfeld Strategic Advisors
Steve Schonfeld is the founder of Schonfeld Strategic Advisors, a multi-manager investment firm with roots in proprietary trading. Schonfeld allocates capital across quantitative and discretionary strategies with an emphasis on risk controls and diversification of return streams. The firm is a major name in the multi-strategy hedge fund landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$5.4B |
| 2 |
NVIDIA
NVDA
|
+$388M |
| 3 |
Microsoft
MSFT
|
+$182M |
| 4 |
Amazon
AMZN
|
+$177M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$163M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$213M |
| 2 |
Broadcom
AVGO
|
+$103M |
| 3 |
Union Pacific
UNP
|
+$100M |
| 4 |
ETHA
iShares Ethereum Trust ETF
ETHA
|
+$89.9M |
| 5 |
Marvell Technology
MRVL
|
+$89.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.68% |
| 2 | Industrials | 8.46% |
| 3 | Financials | 6.55% |
| 4 | Consumer Discretionary | 5.99% |
| 5 | Healthcare | 5.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BRSL
826
Brightstar Lottery PLC
BRSL
$2.16B
| $2.27M | 0.01% |
146,953
+116,544
| +383% | +$1.9M |
|
827
Liquidia Corp
LQDA
$6.29B
| $2.27M | 0.01% |
+65,702
| New | +$1.87M |
|
|
AACB
828
DELISTED
Artius II Acquisition Inc
AACB
| $2.26M | 0.01% |
219,394
-17,105
| -7% | -$175K |
|
829
GeneDx Holdings
WGS
$2.54B
| $2.25M | 0.01% |
17,338
+4,311
| +33% | +$592K |
|
830
SoundHound AI
SOUN
$3.11B
| $2.25M | 0.01% |
226,120
+205,384
| +990% | +$2.96M |
|
831
ONE Gas
OGS
$5.05B
| $2.24M | 0.01% |
29,051
+21,538
| +287% | +$1.73M |
|
832
Sunrun
RUN
$2.15B
| $2.24M | 0.01% |
121,944
-259,502
| -68% | -$4.98M |
|
833
O-I Glass
OI
$1.11B
| $2.22M | 0.01% |
150,577
+124,905
| +487% | +$1.65M |
|
|
OBA
834
Oxley Bridge Acquisition Ltd
OBA
$326M
| $2.22M | 0.01% |
220,447
+35,449
| +19% | +$356K |
|
835
ASP Isotopes
ASPI
$596M
| $2.22M | 0.01% |
414,875
+215,028
| +108% | +$1.71M |
|
836
Huazhu Hotels Group
HTHT
$15B
| $2.21M | 0.01% |
+47,031
| New | +$2.03M |
|
|
LTM
837
LATAM Airlines Group S.A.
LTM
$15.3B
| $2.21M | 0.01% |
+40,845
| New | +$1.93M |
|
838
Graphic Packaging
GPK
$3.39B
| $2.21M | 0.01% |
146,482
-190,248
| -56% | -$3.13M |
|
839
Apogee Therapeutics
APGE
$10.2B
| $2.2M | 0.01% |
+29,145
| New | +$1.84M |
|
840
BioNTech
BNTX
$28.3B
| $2.2M | 0.01% |
+23,078
| New | +$2.33M |
|
841
The Greenbrier Companies
GBX
$1.43B
| $2.18M | 0.01% |
46,661
-41,483
| -47% | -$1.86M |
|
842
Corebridge Financial
CRBG
$14.2B
| $2.18M | 0.01% |
72,231
-228,012
| -76% | -$7.01M |
|
843
NMI Holdings
NMIH
$3.42B
| $2.18M | 0.01% |
53,381
-17,975
| -25% | -$679K |
|
844
Eagle Materials
EXP
$6.27B
| $2.17M | 0.01% |
10,517
+8,979
| +584% | +$1.98M |
|
845
Fabrinet
FN
$15.1B
| $2.17M | 0.01% |
+4,768
| New | +$2.07M |
|
|
SPRB
846
Spruce Biosciences
SPRB
$169M
| $2.16M | 0.01% |
+24,767
| New | +$2.65M |
|
847
Spotify
SPOT
$111B
| $2.16M | 0.01% |
3,714
-63,607
| -94% | -$39.8M |
|
|
848
CALL
Eli Lilly
LLY
$1.11T
| $2.15M | 0.01% |
+2,000
| New | +$1.91M |
|
849
Morgan Stanley Direct Lending Fund
MSDL
$1.29B
| $2.15M | 0.01% |
+130,312
| New | +$2.2M |
|
850
Procept Biorobotics
PRCT
$1.22B
| $2.14M | 0.01% |
68,011
+14,513
| +27% | +$481K |
|
Similar funds
Steve Schonfeld's Q4 2025 Portfolio in Review
As of Q4 2025, Steve Schonfeld held 2,774 positions worth $22.6B, up 28% from $17.6B the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Steve Schonfeld deployed $4.53B of net new capital in Q4 2025, opening 620 new positions and adding to 589 existing holdings. Its largest new stake was Medline Inc: 1,945,050 shares worth $81.7M.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 14% a quarter earlier, followed by Industrials and Financials.
On the sell side, the largest reduction was Eli Lilly, an estimated $213M trimmed.
- Steve Schonfeld's largest Q4 2025 buy was Medline Inc: 1,945,050 shares worth $81.7M.
- Steve Schonfeld added most to iShares Core S&P 500 ETF in Q4 2025, an estimated $5.4B increase.
- Steve Schonfeld's biggest Q4 2025 reduction was Eli Lilly, cutting an estimated $213M.
- Steve Schonfeld fully exited Southwest Airlines in Q4 2025, selling an estimated $73.9M.
- Steve Schonfeld's ten largest holdings make up 41% of its $22.6B portfolio in Q4 2025.
- Steve Schonfeld opened 620 new positions and closed 789 in Q4 2025.
- Steve Schonfeld's portfolio value rose 28% quarter-over-quarter to $22.6B.
Based on Schonfeld Strategic Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.